OncoVAX Image

News

Vaccinogen Alerts

You can automatically receive Vaccinogen News alerts. Please enter your name and e-mail address below, then click "Submit" - As news items are posted, they will be sent to you via e-mail.

Click Here for the
Vaccinogen Press Kit

May 5, 2010
Vaccinogen Selects Clinipace Worldwide to Manage Global Phase 3b Clinical Trial
October 22, 2009
Vaccinogen Announces New Relationship with CRO Clinipace Worldwide
July 24, 2009
Vaccinogen Announces Submission of Final Documentation to Swissmedic for Pivotal Review of OncoVAX®
July 17, 2009
Vaccinogen Announces That Michael G. Hanna, Jr., Ph.D. is Scheduled to Speak at the Vaccine Discovery & Development Conference in Brussels, Belgium in November
May 15, 2009
Vaccinogen Announces Establishment of a Distribution Relationship with Deutsches Grunes Kreuz ("DGK") for Distribution of OncoVAX in Germany
April 20, 2009
Vaccinogen Announces That Michael G. Hanna, Jr., Ph.D. is Scheduled to Speak at the Barcelona Vaccine Forum 2009 in June 2009
March 1, 2009
Vaccinogen Announces Addition of David Hatt to its Board of Directors
November 14, 2008
Vaccinogen Announces that Swissmedic Health Authorities Granted Its Swiss Distribution Partner, ProVaccine, Permission to Export Biopsies and Import Vaccines on behalf of Vaccinogen.
November 13, 2008
OncoVAX, Other Vaccines Provide Hope for Colorectal Cancer Treatment, Prevention
June 4, 2008
Thomson Reuters' Pharma Matters highlights Vaccinogen’s OncoVAX® as “One to Watch”
May 7, 2008
Dutch Authorize Manufacture of Vaccinogen’s New Cancer Vaccine; License Clears Path to European Production, Final FDA Trial
February 27, 2008
Vaccinogen's New Anti-Cancer Vaccine Commercially Available in Europe This Year
February 11, 2008
Cancer Pioneer Reaches Key Agreement On Colon Cancer Drug OncoVAX®
November 10, 2007
Vaccinogen Announces the Successful Acquisition of Key Management and Staff
November 4, 2007
Vaccinogen Announces Successful Acquisition of cGMP Manufacturing Facility
November 3, 2007
Vaccinogen Announces Completion of its Initial Capitalization Plan
October 1, 2007
Vaccinogen Announces Formation of Company
July 19, 2006
FDA Grants Special Protocol Assessment
July 1, 2006
FDA Grants Intracel “Fast Track” Designation for the Development of Its Colon Cancer Vaccine
Site credit: idfive, the interactive division of growth5